Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...

The FDA approved Pfizer’s Hympavzi, which can be an alternative to intravenous infusions often administered multiple times a ...

Story of activist fund Starboard Value taking $1B position in Pfizer is grabbing headlines the last few days. Read why I ...

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...

The new drug would allow patients to produce the needed clotting protein for an extended period, reducing the need for ...

Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current ...